$39.66—Stale · unknown old
NYSE • Last print unknown agoAbout this data
$39.66—Stale · unknown old
TEVA News
About
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
Kaare Schultz
Country
Israel
Website
Leadership (10)
Eric A. HughesExecutive Vice President of Global R&D and Chief Medical Officer
Evan LippmanExecutive Vice President of Business Development
Richard FrancisPresident, Chief Executive Officer & Director
Christine FoxExecutive VP of US Commercial & Head of Innovative Franchise
Amir WeissSenior Vice President & Chief Accounting Officer
Christopher J. StevoSenior Vice President of Investor Relations & Competitive Intelligence
Kathleen VeitSenior Vice President, Global Compliance & Ethics Officer
Matthew ShieldsExecutive Vice President of Global Operations
Brian SavageInterim Chief Legal Officer
Eliyahu Sharon KalifExecutive Vice President & Chief Financial Officer
Explore More
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers